Go to Healthcare Professionals Site
Customer Contact Center:
1-888-PLMZYME (756-9963)

Indication and Usage

Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics.

In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.

Important Safety Information

  • Pulmozyme should not be used in patients who are allergic to any of its ingredients. Pulmozyme should be used along with standard therapies for cystic fibrosis.
  • When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose.
  • These side effects are usually mild and short-lived.

For further information, please see the Pulmozyme full prescribing information. If you have questions, please discuss them with your CF healthcare team.

Patient Financial Support

Financial Support

Visit CF Living
This online community is a place for CF patients and caregivers to get advice, share stories and learn about others fighting this disease.

We are here to help you get the treatment you need.

Genentech has been committed to CF for over 17 years and can connect you with the medicine you need. We offer programs to help eligible patients get Pulmozyme, regardless of ability to pay.

Pulmozyme Access Solutions®. If you are worried about paying for Pulmozyme, we are here to help. Whether you have healthcare coverage or not, we offer help by:

  • Finding out if your healthcare plan pays for your medicine
  • Guiding you through the process of getting your medicine
  • Connecting you with our patient financial assistance programs

Learn more ›

Pulmozyme Co-Pay Card Program. If you are concerned about your co-pay, you may be eligible for our Pulmozyme Access Solutions Co-Pay Card Program. This program may help you with the out-of-pocket (OOP) costs of your Pulmozyme prescription.
Learn more ›

Genentech® Access to Care Foundation. If you do not have health insurance and/or cannot afford the cost of Pulmozyme, you may be eligible to receive your medicine free of charge. Learn more ›

Next:
Pulmozyme Access Solutions ›